CVRx, Inc.

NASDAQ:CVRX

Medical - Devices

Healthcare
$2.63 +2.28%

+$0.11 today

Market cap
$69.79M
Beta
0.77
P/E (TTM)
-2.5
EPS (TTM)
-$2.00
52W Low $4.37High $11.30

Volume 0.37M

Average 0.30M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$40.17M

FY 2025 · Annual

Investing Cash Flow

-$580,000.00

FY 2025 · Annual

Financing Cash Flow

$10.52M

FY 2025 · Annual

-81.2% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(43.08M)(41.43M)(41.2M)(59.97M)(53.31M)
Depreciation & Amortization168K412K522K619K756K
Deferred Income Tax14.62M0000
Stock-Based Compensation1.91M3.89M6.3M19.05M11.05M
Change in Working Capital(1.58M)(5.57M)(4.81M)949K1M
Accounts Receivables(1.28M)(2.94M)(2.05M)(1.72M)(1.4M)
Inventory(537K)(3.08M)(4.03M)(1.12M)(98K)
Accounts Payables27K1.21M165K698K1.25M
Other Working Capital207K(761K)1.1M3.09M1.25M
Other Non-Cash Items229K25K158K203K327K
Operating Cash Flow(27.73M)(42.68M)(39.02M)(39.14M)(40.17M)
Capital Expenditures(1.18M)(685K)(591K)(1.36M)(580K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(1.18M)(685K)(591K)(1.36M)(580K)
Debt Repayment(21.3M)7.5M22.5M20M0
Common Stock Issued133.16M771K1.66M32.52M10.52M
Common Stock Repurchased(1K)0000
Dividends Paid00000
Other Financing Activities23K(7K)1.48M3.35M0
Financing Cash Flow111.88M7.49M23.98M55.87M10.52M
Effect of Forex Changes(8K)(9K)3K(1K)5K
Net Change in Cash82.96M(35.88M)(15.63M)15.36M(30.23M)
Free Cash Flow(28.92M)(43.36M)(39.61M)(40.51M)(40.75M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$53.3M
+ D&A$756.0K
+ Stock-Based Comp$11.1M
+ Deferred Tax$0
+ Working Capital$1.0M
+ Other Non-Cash$327.0K
= Operating Cash Flow-$40.2M
- Capex-$580.0K
= Free Cash Flow-$40.8M

Analysis

FY2025 free cash flow is -$40.8M. FCF conversion is 76.4% of net income. Operating cash flow was -$40.2M, with capex of -$580.0K. The largest bridge item is Stock-Based Comp at $11.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 21, 2026
SC 13DSC 13D filingAug 24, 2026
SC 13GSC 13G filingAug 14, 2026
4Statement of changes in beneficial ownershipAug 13, 2026
4Statement of changes in beneficial ownershipAug 13, 2026

Does CVRX generate free cash flow?

CVRx, Inc. (CVRX) generated -$40.75M of free cash flow in fiscal 2025.

How much operating cash flow does CVRX produce?

Operating cash flow was -$40.17M, before capital expenditures of $580,000.00.